Evidence map›Paper›PMID 30837651›Full record

ArticleScientific reports2019

DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass.

Scott M Gordon, Edward B Neufeld, Zhihong Yang, Milton Pryor, Lita A Freeman, Xiao Fan, Iftikhar J Kullo, Leslie G Biesecker, Alan T Remaley

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Scott M GordonTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA. scott.gordon@uky.edu.
Edward B NeufeldTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA.
Zhihong YangTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA.
Milton PryorTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA.
Lita A FreemanTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA.
Xiao FanDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, 55905, USA.
Iftikhar J KulloDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, 55905, USA.
Leslie G BieseckerMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland, 20892, USA.ORCID 0000-0002-0197-3811
Alan T RemaleyTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, 20892, USA.
National Heart Lung and Blood Institute · USMayo Clinic · USNational Human Genome Research Institute · USUniversity of Kentucky · US

Funding

Rare & Mosaic Disorders Molecular ResearchZIAHG200328 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BIESECKER, LESLIE · 2009 to 2025
$26.8M
Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
Use Of Animal Models To Study Lipid Genes That Modulate AtherosclerosisZIAHL002058 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI REMALEY, ALAN THOMAS · 2009 to 2019
$14.3M
Biomarkers of Peripheral Arterial DiseaseR01HL075794 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2003 to 2007
$3.0M
EHR-Based Strategies to Improve Outcomes in Familial HypercholesterolemiaR01HL135879 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2017 to 2020
$2.5M
Patient-Oriented Research in Genomic Discovery and ImplementationK24HL137010 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2017 to 2021
$590k
NHGRI NIH HHS U01 HG006379NHLBI NIH HHS K24 HL137010NHLBI NIH HHS R01 HL075794NHLBI NIH HHS R01 HL135879U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) IRP
6 · The paper itself

Abstract

Regulation of lipid absorption by enterocytes can influence metabolic status in humans and contribute to obesity and related complications. The intracellular steps of chylomicron biogenesis and transport from the Endoplasmic Reticulum (ER) to the Golgi complex have been described, but the mechanisms for post-Golgi transport and secretion of chylomicrons have not been identified. Using a newly generated Dennd5b

Indexed as

Body Mass IndexIntestinal AbsorptionAnimalsBiological TransportDeath Domain Receptor Signaling Adaptor ProteinsDiet, High-FatEndoplasmic ReticulumFemaleGolgi ApparatusLipid MetabolismMaleMiceMice, KnockoutObesityTriglyceridesDeath Domain Receptor Signaling Adaptor ProteinsTriglycerides

Identifiers

PMID30837651
PMCPMC6401118
OpenAlexW2918465522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.